Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.010 |
None |
< 0.001 |
1 |
|
1997 |
1997 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Seminal Vesicle Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
219
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2004 |
2004 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.010 |
None |
< 0.001 |
1 |
|
1997 |
1997 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Dopa-Responsive Dystonia
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
28
|
33
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2000 |
2000 |
Female Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.020 |
None |
0.500 |
2 |
|
1997 |
1998 |
Malignant neoplasm of female breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.020 |
None |
0.500 |
2 |
|
1997 |
1998 |
Carcinoma, Small Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
185
|
7
|
0.020 |
None |
0.500 |
2 |
|
2011 |
2019 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.090 |
None |
0.556 |
9 |
|
1995 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.060 |
None |
0.667 |
6 |
|
2018 |
2020 |
Overactive Bladder
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
65
|
3
|
0.030 |
None |
0.667 |
3 |
1
|
2017 |
2019 |
Substance Withdrawal Syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
80
|
5
|
0.030 |
None |
0.667 |
3 |
|
2000 |
2018 |
Prostatic Intraepithelial Neoplasias
|
disease |
Neoplasms
|
Neoplastic Process
|
230
|
|
0.040 |
None |
0.750 |
4 |
|
2008 |
2017 |
Lupus anticoagulant disorder
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
66
|
14
|
0.040 |
None |
0.750 |
4 |
|
2017 |
2018 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.100 |
None |
0.846 |
13 |
|
1990 |
2020 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.070 |
None |
0.857 |
7 |
|
2001 |
2017 |
Prostatic Diseases
|
group |
Male Urogenital Diseases
|
Disease or Syndrome
|
72
|
4
|
0.100 |
None |
0.889 |
18 |
|
1994 |
2020 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.090 |
None |
0.889 |
9 |
|
2002 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.090 |
None |
0.889 |
9 |
|
2002 |
2018 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.100 |
None |
0.893 |
28 |
|
2013 |
2020 |